Yu, M., Yuan, G. Y., Zhang, B., Wu, H. Y., & Lv, X. F. (2020). Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis. Diabetes Therapy, 11(5), 1147. https://doi.org/10.1007/s13300-020-00804-2
Chicago Style (17th ed.) CitationYu, Miao, Guo Yue Yuan, Bin Zhang, Hai Ya Wu, and Xiao Feng Lv. "Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis." Diabetes Therapy 11, no. 5 (2020): 1147. https://doi.org/10.1007/s13300-020-00804-2.
MLA (9th ed.) CitationYu, Miao, et al. "Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis." Diabetes Therapy, vol. 11, no. 5, 2020, p. 1147, https://doi.org/10.1007/s13300-020-00804-2.